$1.39 Billion is the total value of Logos Global Management LP's 57 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 56.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALXO | ALX ONCOLOGY HLDGS INC | $233,175,000 | +35.1% | 3,156,981 | 0.0% | 16.81% | +15.9% | |
| OLMA | OLEMA PHARMACEUTICALS INC | $103,181,000 | -1.5% | 3,743,875 | 0.0% | 7.44% | -15.5% | |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $62,863,000 | +56.1% | 1,850,000 | +68.2% | 4.53% | +34.0% |
| BCYC | Buy | BICYCLE THERAPEUTICS PLCsponsored ads | $61,345,000 | +182.6% | 1,475,000 | +106.3% | 4.42% | +142.5% |
| DYN | Buy | DYNE THERAPEUTICS INC | $58,779,000 | +36.0% | 3,619,392 | +76.2% | 4.24% | +16.7% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $56,272,000 | +51.9% | 460,000 | +41.5% | 4.06% | +30.3% |
| FMTX | Buy | FORMA THERAPEUTICS HLDGS INC | $49,047,000 | +62.2% | 2,115,000 | +74.1% | 3.54% | +39.1% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $47,792,000 | +116.1% | 1,450,000 | +314.3% | 3.45% | +85.4% |
| IDYA | New | IDEAYA BIOSCIENCES INC | $45,245,000 | – | 1,775,000 | +100.0% | 3.26% | – |
| CMPS | Buy | COMPASS PATHWAYS PLCsponsored ads | $41,818,000 | +29.0% | 1,400,000 | +64.7% | 3.02% | +10.6% |
| PMVP | Buy | PMV PHARMACEUTICALS INC | $41,720,000 | +491.3% | 1,400,000 | +577.8% | 3.01% | +407.3% |
| DSGN | Buy | DESIGN THERAPEUTICS INC | $40,728,000 | -25.1% | 2,772,501 | +1.5% | 2.94% | -35.7% |
| New | DICE THERAPEUTICS INC | $37,998,000 | – | 1,160,251 | +100.0% | 2.74% | – | |
| CYTK | Sell | CYTOKINETICS INC | $35,740,000 | +29.0% | 1,000,000 | -28.6% | 2.58% | +10.7% |
| NKTX | Buy | NKARTA INC | $35,479,000 | +11.7% | 1,275,777 | +27.3% | 2.56% | -4.2% |
| KZR | Buy | KEZAR LIFE SCIENCES INC | $35,424,000 | +183.6% | 4,100,000 | +78.3% | 2.55% | +143.2% |
| ALGS | Buy | ALIGOS THERAPEUTICS INC | $30,443,000 | +601.6% | 1,962,785 | +822.4% | 2.20% | +501.4% |
| ARNA | New | ARENA PHARMACEUTICALS INC | $30,371,000 | – | 510,000 | +100.0% | 2.19% | – |
| VRDN | New | VIRIDIAN THERAPEUTICS INC | $24,675,000 | – | 1,500,000 | +100.0% | 1.78% | – |
| TIL | Sell | INSTIL BIO INC | $22,828,000 | -30.4% | 1,277,091 | -24.7% | 1.65% | -40.3% |
| VERV | Sell | VERVE THERAPEUTICS INC | $20,833,000 | -54.4% | 443,265 | -41.5% | 1.50% | -60.9% |
| LABP | Buy | LANDOS BIOPHARMA INC | $20,513,000 | +97.5% | 1,405,000 | +56.3% | 1.48% | +69.4% |
| GRPH | Buy | GRAPHITE BIO INC | $19,771,000 | -39.9% | 1,206,308 | +12.7% | 1.43% | -48.4% |
| CNTA | Buy | CENTESSA PHARMACEUTICALS PLCsponsored ads | $17,861,000 | -14.4% | 1,069,545 | +13.8% | 1.29% | -26.6% |
| New | TYRA BIOSCIENCES INC | $17,650,000 | – | 1,003,394 | +100.0% | 1.27% | – | |
| ATHA | Buy | ATHIRA PHARMA INC | $17,408,000 | +20.5% | 1,855,812 | +31.5% | 1.26% | +3.4% |
| IPSC | Sell | CENTURY THERAPEUTICS INC | $16,080,000 | -44.6% | 639,095 | -35.4% | 1.16% | -52.4% |
| JNCE | New | JOUNCE THERAPEUTICS INC | $14,860,000 | – | 2,000,000 | +100.0% | 1.07% | – |
| PRLD | PRELUDE THERAPEUTICS INC | $12,500,000 | +9.2% | 400,000 | 0.0% | 0.90% | -6.3% | |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $12,330,000 | -57.9% | 500,000 | -55.6% | 0.89% | -63.9% |
| EWTX | Sell | EDGEWISE THERAPEUTICS INC | $10,752,000 | -59.1% | 681,812 | -44.6% | 0.78% | -64.9% |
| BMEA | Sell | BIOMEA FUSION INC | $8,407,000 | -53.7% | 702,320 | -39.6% | 0.61% | -60.3% |
| ELDN | ELEDON PHARMACEUTICALS INC | $8,280,000 | -21.9% | 1,339,793 | 0.0% | 0.60% | -33.0% | |
| EPIX | New | ESSA PHARMA INC | $8,000,000 | – | 1,000,000 | +100.0% | 0.58% | – |
| ALT | New | ALTIMMUNE INC | $7,917,000 | – | 700,000 | +100.0% | 0.57% | – |
| COGT | Sell | COGENT BIOSCIENCES INC | $7,779,000 | -32.5% | 925,000 | -34.9% | 0.56% | -42.0% |
| BCEL | New | ATRECA INC | $7,320,000 | – | 1,175,000 | +100.0% | 0.53% | – |
| TALS | TALARIS THERAPEUTICS INC | $6,887,000 | -7.7% | 507,923 | 0.0% | 0.50% | -20.7% | |
| RAIN | Sell | RAIN THERAPEUTICS INC | $6,613,000 | -45.5% | 465,331 | -40.4% | 0.48% | -53.2% |
| CGEM | CULLINAN ONCOLOGY INC | $6,510,000 | -12.4% | 288,458 | 0.0% | 0.47% | -24.8% | |
| GHRS | Sell | GH RESEARCH PLCordinary shares | $6,439,000 | -59.1% | 324,333 | -55.2% | 0.46% | -64.9% |
| JANX | Sell | JANUX THERAPEUTICS INC | $4,811,000 | -64.8% | 247,122 | -54.8% | 0.35% | -69.7% |
| SYBX | New | SYNLOGIC INC | $4,575,000 | – | 1,500,000 | +100.0% | 0.33% | – |
| ALPN | New | ALPINE IMMUNE SCIENCES INC | $4,535,000 | – | 425,000 | +100.0% | 0.33% | – |
| STTK | New | SHATTUCK LABS INC | $4,076,000 | – | 200,000 | +100.0% | 0.29% | – |
| IKNA | IKENA ONCOLOGY INC | $3,784,000 | -10.1% | 299,853 | 0.0% | 0.27% | -22.9% | |
| DAWN | Buy | DAY ONE BIOPHARMACEUTICALS I | $2,798,000 | +231.5% | 52,069 | +40.5% | 0.20% | +184.5% |
| New | NUVALENT INC | $2,733,000 | – | 134,650 | +100.0% | 0.20% | – | |
| New | SOMALOGIC INC | $2,236,000 | – | 200,493 | +100.0% | 0.16% | – | |
| KNTE | Sell | KINNATE BIOPHARMA INC | $2,172,000 | -93.0% | 94,345 | -92.9% | 0.16% | -94.0% |
| New | OMEGA THERAPEUTICS INC | $1,663,000 | – | 88,235 | +100.0% | 0.12% | – | |
| PASG | PASSAGE BIO INC | $1,245,000 | -24.8% | 125,010 | 0.0% | 0.09% | -35.3% | |
| GLUE | Sell | MONTE ROSA THERAPEUTICS INC | $1,114,000 | -83.6% | 50,000 | -83.3% | 0.08% | -86.0% |
| KROS | New | KEROS THERAPEUTICS INC | $593,000 | – | 15,000 | +100.0% | 0.04% | – |
| RPTX | Sell | REPARE THERAPEUTICS INC | $525,000 | -94.9% | 20,000 | -93.9% | 0.04% | -95.6% |
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $177,000 | +2.3% | 66,666 | 0.0% | 0.01% | -13.3% | |
| MREO | MEREO BIOPHARMA GROUP PLCads | $114,000 | -23.5% | 46,984 | 0.0% | 0.01% | -38.5% | |
| HLXA | Exit | HELIX ACQUISITION CORP | $0 | – | -50,000 | -100.0% | -0.04% | – |
| RACB | Exit | RESEARCH ALLIANCE CORP II | $0 | – | -100,000 | -100.0% | -0.08% | – |
| HSAQ | Exit | HEALTH SCIENCES ACQ CORP 2 | $0 | – | -100,000 | -100.0% | -0.09% | – |
| FSII | Exit | FS DEVELOPMENT CORP II | $0 | – | -123,543 | -100.0% | -0.10% | – |
| ARYD | Exit | ARYA SCIENCES ACQU CORP IVcl a | $0 | – | -200,000 | -100.0% | -0.18% | – |
| BCTG | Exit | BCTG ACQUISITION CORP | $0 | – | -200,000 | -100.0% | -0.19% | – |
| ANNX | Exit | ANNEXON INC | $0 | – | -159,622 | -100.0% | -0.30% | – |
| CCCC | Exit | C4 THERAPEUTICS INC | $0 | – | -112,928 | -100.0% | -0.36% | – |
| ASLN | Exit | ASLAN PHARMACEUTICALS LTDads | $0 | – | -2,000,000 | -100.0% | -0.56% | – |
| Exit | CATABASIS PHARMACEUTICALS IN | $0 | – | -3,190,000 | -100.0% | -0.57% | – | |
| RAPT | Exit | RAPT THERAPEUTICS INC | $0 | – | -270,000 | -100.0% | -0.72% | – |
| HARP | Exit | HARPOON THERAPEUTICS INC | $0 | – | -800,000 | -100.0% | -0.93% | – |
| KNSA | Exit | KINIKSA PHARMACEUTICALS LTD | $0 | – | -800,000 | -100.0% | -0.94% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -675,000 | -100.0% | -1.00% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -2,500,000 | -100.0% | -1.33% | – |
| RAPT | Exit | RAPT THERAPEUTICS INCcall | $0 | – | -750,000 | -100.0% | -2.00% | – |
| TPTX | Exit | TURNING POINT THERAPEUTICS I | $0 | – | -400,000 | -100.0% | -2.62% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 14 | Q3 2023 | 12.6% |
| KARUNA THERAPEUTICS INC | 14 | Q3 2023 | 5.6% |
| ALX ONCOLOGY HLDGS INC | 13 | Q3 2023 | 23.3% |
| DYNE THERAPEUTICS INC | 13 | Q3 2023 | 4.9% |
| APELLIS PHARMACEUTICALS INC | 12 | Q3 2023 | 12.4% |
| OLEMA PHARMACEUTICALS INC | 12 | Q3 2023 | 15.4% |
| DESIGN THERAPEUTICS INC | 11 | Q3 2023 | 8.0% |
| NUVATION BIO INC | 11 | Q3 2023 | 0.0% |
| BICYCLE THERAPEUTICS PLC | 10 | Q2 2023 | 5.7% |
| IDEAYA BIOSCIENCES INC | 9 | Q3 2023 | 9.5% |
View Logos Global Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | July 18, 2023 | 6,350,000 | 8.1% |
| BICYCLE THERAPEUTICS plc | February 14, 2023 | 1,435,000 | 4.8% |
| Dyne Therapeutics, Inc. | February 14, 2023 | 2,150,000 | 4.1% |
| Design Therapeutics, Inc. | March 31, 2022 | 2,797,501 | 5.0% |
| IDEAYA Biosciences, Inc. | March 18, 2022 | 2,650,000 | 6.9% |
| Aligos Therapeutics, Inc. | February 14, 2022 | ? | ? |
| Cogent Biosciences, Inc. | February 14, 2022 | 150,000 | 0.4% |
| Kezar Life Sciences, Inc. | February 14, 2022 | 1,450,000 | 3.0% |
| Nkarta, Inc. | February 14, 2022 | ? | ? |
| Viridian Therapeutics, Inc.\DE | February 14, 2022 | ? | ? |
View Logos Global Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-01 |
| SC 13G | 2024-02-22 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-01-22 |
| SC 13G | 2024-01-22 |
| SC 13G | 2024-01-02 |
View Logos Global Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.